CoChat

Pharmacological Treatment of Cognitive Dysfunction in Neuropsychiatric Disorders

Venero, César · 2015 · Cognitive Enhancement

The DOI matches its Crossref record; 287 of the 287 references it cites were found in a registry or an index.

Overview

Integrity signals

Registry

Crossref · 10.1016/b978-0-12-417042-1.00010-3

Cites

287 of 287 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 287 references

Research works printed but not linked: 2

  1. Biederman, 2008, Effects of stimulant medication on neuropsychological functioning in young adults with attention-deficit/hyperactivity disorder, J. Clin. Psychiatry, 69, 1150, 10.4088/JCP.v69n0715 · DOI · Paper page
  2. Kantrowitz, 2011, Glutamate: new hope for schizophrenia treatment, Curr. Psychiatry, 10, 69

Cited by

See all 4

Metadata

Authors
Venero, C.
Affiliations
Universidad Nacional de Educación a Distancia (ES)
Corresponding author
Venero, César
Venue
Cognitive Enhancement
Publisher
Elsevier
Published
2015
Pages
233-271
OpenAlex
W259353220
Cited by
4
References
287
Citations by year
2019: 1 · 2018: 3
FWCI
6.24
Type
book chapter
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
Elsevier eBooks (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
Keywords
cognitive impairment, neuropsychiatric disorders, nootropic drugs, cognitive enhancement, Alzheimer's disease, attention deficit hyperactivity disorder, schizophrenia, bipolar disorder, major depressive disorder, post-traumatic stress disorder, memory, attention, executive function, pharmacotherapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacological Treatment of Cognitive Dysfunction in Neuropsychiatric Disorders. https://app.cochat.ai/papers/10.1016/b978-0-12-417042-1.00010-3
The paper
Venero, C. (2015). Pharmacological Treatment of Cognitive Dysfunction in Neuropsychiatric Disorders. Cognitive Enhancement. https://doi.org/10.1016/b978-0-12-417042-1.00010-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.